CA1068695A - Amines - Google Patents

Amines

Info

Publication number
CA1068695A
CA1068695A CA265,534A CA265534A CA1068695A CA 1068695 A CA1068695 A CA 1068695A CA 265534 A CA265534 A CA 265534A CA 1068695 A CA1068695 A CA 1068695A
Authority
CA
Canada
Prior art keywords
radical
formula
hydrogen
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA265,534A
Other languages
English (en)
French (fr)
Inventor
Clifford R. Hughes
Stephen J. Jackson
John Preston
Peter L. Walton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA1068695A publication Critical patent/CA1068695A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA265,534A 1975-11-25 1976-11-12 Amines Expired CA1068695A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48402/75A GB1559977A (en) 1975-11-25 1975-11-25 Amines

Publications (1)

Publication Number Publication Date
CA1068695A true CA1068695A (en) 1979-12-25

Family

ID=10448487

Family Applications (1)

Application Number Title Priority Date Filing Date
CA265,534A Expired CA1068695A (en) 1975-11-25 1976-11-12 Amines

Country Status (28)

Country Link
US (1) US4105790A (en:Method)
JP (2) JPS5265240A (en:Method)
AR (1) AR215871A1 (en:Method)
AT (1) AT348993B (en:Method)
AU (1) AU503657B2 (en:Method)
BE (1) BE848707A (en:Method)
CA (1) CA1068695A (en:Method)
CH (1) CH624383A5 (en:Method)
CS (1) CS196333B2 (en:Method)
DD (1) DD127474A5 (en:Method)
DE (1) DE2653635C2 (en:Method)
DK (1) DK531276A (en:Method)
ES (2) ES453632A1 (en:Method)
FI (1) FI763399A7 (en:Method)
FR (1) FR2332747A1 (en:Method)
GB (1) GB1559977A (en:Method)
IE (1) IE44030B1 (en:Method)
IL (1) IL50904A (en:Method)
IN (1) IN145003B (en:Method)
LU (1) LU76251A1 (en:Method)
NL (1) NL7613081A (en:Method)
NO (1) NO764012L (en:Method)
NZ (1) NZ182581A (en:Method)
PL (2) PL105491B1 (en:Method)
PT (1) PT65892B (en:Method)
SE (1) SE7613079L (en:Method)
SU (1) SU722481A3 (en:Method)
ZA (1) ZA766696B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02130656U (en:Method) * 1989-03-31 1990-10-29
JPH028457U (en:Method) * 1988-07-01 1990-01-19
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
HU226037B1 (en) * 1993-06-25 2008-03-28 Aventis Inc Process for producing antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives and novel intermediates
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
US6700012B2 (en) 1998-07-02 2004-03-02 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
FR2880887B1 (fr) * 2005-01-14 2009-01-30 Merck Sante Soc Par Actions Si Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
EP3170844A4 (en) * 2014-07-16 2018-01-10 Adeka Corporation Photosensitive composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques

Also Published As

Publication number Publication date
LU76251A1 (en:Method) 1977-12-13
PT65892B (en) 1978-05-18
PL105491B1 (pl) 1979-10-31
AT348993B (de) 1979-03-12
NO764012L (en:Method) 1977-05-26
PT65892A (en) 1976-12-01
AU1962576A (en) 1978-05-25
SU722481A3 (ru) 1980-03-15
JPS6360004B2 (en:Method) 1988-11-22
JPS5265240A (en) 1977-05-30
FR2332747B1 (en:Method) 1980-03-14
US4105790A (en) 1978-08-08
DK531276A (da) 1977-05-26
NL7613081A (nl) 1977-05-27
AU503657B2 (en) 1979-09-13
PL105799B1 (pl) 1979-10-31
PL193861A1 (pl) 1978-03-28
ATA870976A (de) 1978-08-15
SE7613079L (sv) 1977-05-26
JPS61158922A (ja) 1986-07-18
FR2332747A1 (fr) 1977-06-24
ES465152A1 (es) 1978-10-01
ZA766696B (en) 1977-10-26
ES453632A1 (es) 1978-03-16
NZ182581A (en) 1978-09-20
IL50904A (en) 1980-02-29
IN145003B (en:Method) 1978-08-12
DE2653635A1 (de) 1977-06-02
CH624383A5 (en:Method) 1981-07-31
JPS6120538B2 (en:Method) 1986-05-22
IE44030L (en) 1977-05-25
DD127474A5 (en:Method) 1977-09-28
FI763399A7 (en:Method) 1977-05-26
GB1559977A (en) 1980-01-30
AR215871A1 (es) 1979-11-15
DE2653635C2 (de) 1986-10-02
BE848707A (fr) 1977-05-24
CS196333B2 (en) 1980-03-31
IE44030B1 (en) 1981-07-29

Similar Documents

Publication Publication Date Title
RU2112772C1 (ru) Производные 2-циано-3-гидроксиенамидов, способы их получения, фармацевтическая композиция на их основе
EP0061386B1 (fr) Acides ((2-oxo-3-tétrahydrothiénylcarbamoyl)-alkylthio) acétiques, leurs sels et leurs esters, leur procédé de préparation et les compositions pharmaceutiques en contenant
CA1068695A (en) Amines
FR2517302A1 (fr) Esters et amides de 13 14-bisdehydroprostaglandines
US4317915A (en) Novel thiophene derivatives
EP0022118A1 (fr) Nouveaux dérivés de sulfonyl-aniline, leur procédé de préparation et leur application en thérapeutique
US4985445A (en) Cancer cell metastasis inhibitors and novel compounds
US4430355A (en) Condensed isothiazolo-3 (2H)-one-1-1-dioxides
US5196567A (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
US3892769A (en) Acetaminophen esters of aryl salicylic acids
US6569897B1 (en) Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
US5250545A (en) Cancer cell metastasis inhibitor methods
US4542158A (en) Prodrug esters of diflunisal and related compounds
IE893332L (en) Prodrugs of antiinflammatory¹3-acyl-2-oxindole-1-carboxamides
EP0082404A1 (en) Novel forms of diflunisal and related compounds
US3641146A (en) Halocolchicine derivatives
DK154214B (da) Analogifremgangsmaade til fremstilling af 2-oxabicyclo-(3,3,0)octanderivater
IE44047B1 (en) Process for the preparation of cyanoacetic acid anilide derivatives
US4766148A (en) Biphenylylpropionic acid derivative and pharmaceutical composition containing the same
US4923888A (en) Butenoic acid amides, their salts, and pharmaceutical compositions containing them
US4762944A (en) Butenoic acid derivatives, pharmaceutical compositions containing them and process for preparing same
IE45417B1 (en) Napthalene derivatives
FR2581996A1 (fr) Nouveaux derives 6-substitues de 6h-dibenzo(b, d)thiopyranne utiles notamment immunomodulateurs et antiviraux et leur preparation
US4115545A (en) Pharmaceutical composition containing prostadienoic acid for regulating gastric secretion
EP0103265A2 (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same